Thursday, October 18, 2012

Chinese Outbond Investments


  • Shenzhen Hepalink Pharmaceutical Co. -Chinese heparin sodium API supplier- said it would subscribe 48.1mn new shares issued by Canadian protein technologies provider ProMetic Life Science Inc, representing 10% of ProMetic's enlarged share capital, for CAD 9.79 Million (USD 10 Million).
  • Chinese petroleum trader Sinopec Kantons said it agreed to acquire a 50% stake in Netherlands-based terminal storage services company Vesta Terminals from international energy group Mercuria for EUR 128.6 Million (USD 166.6 Million).

No comments:

Post a Comment